Ketamine Trial for the Treatment of Depression

Phase 1

Completed

• Conditions: Unipolar Depression
• Interventions: Drug: Ketamine; Drug: Placebo

• Registration Number: NCT02401139
• Lead Sponsor: The University of New South Wales

Brief Summary

This study is a Randomized Controlled Trial, investigating the safety and efficacy of administration of ketamine as a potential treatment for depression.

Detailed Description

Not available

Study Timeline

• Status Verified: 2015-03
• Study Start: 2015-03
• Study First Submitted: 2015-03-24
• Study First Submitted QC: 2015-03-26
• Study First Posted: 2015-03-27
• Primary Completion: 2015-07
• Study Completion: 2015-09
• Last Update Submitted: 2023-03-28
• Last Update Posted: 2023-03-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Treatment arm	Ketamine	Ketamine
Placebo arm	Placebo	Placebo

Primary Outcome Measures

Name	Time	Method
Montgomery Asberg Depression Rating Scale for Depression (MADRS)	4 weeks

Trial Locations

Locations (2)

Brain & Mind Research Institute (BMRI), University of Sydney; 🇦🇺 Camperdown, New South Wales, Australia

Black Dog Institute, University of New South Wales; 🇦🇺 Sydney, New South Wales, Australia